Russell Investments Group Ltd. trimmed its stake in VWR Corp (NASDAQ:VWR) by 25.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,140,544 shares of the medical research company’s stock after selling 389,244 shares during the period. Russell Investments Group Ltd. owned approximately 0.87% of VWR worth $37,763,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. BlackRock Inc. increased its holdings in VWR by 4,641.8% during the 1st quarter. BlackRock Inc. now owns 4,072,333 shares of the medical research company’s stock worth $114,840,000 after purchasing an additional 3,986,452 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of VWR by 4.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,407,239 shares of the medical research company’s stock valued at $39,684,000 after acquiring an additional 60,009 shares during the period. State Street Corp increased its holdings in shares of VWR by 6.9% in the 1st quarter. State Street Corp now owns 1,087,711 shares of the medical research company’s stock valued at $30,676,000 after acquiring an additional 70,106 shares during the period. Colony Group LLC increased its holdings in shares of VWR by 6.5% in the 2nd quarter. Colony Group LLC now owns 144,191 shares of the medical research company’s stock valued at $4,760,000 after acquiring an additional 8,835 shares during the period. Finally, Aperio Group LLC grew its stake in VWR by 7.5% during the 3rd quarter. Aperio Group LLC now owns 53,329 shares of the medical research company’s stock worth $1,766,000 after buying an additional 3,721 shares during the last quarter. 96.66% of the stock is owned by institutional investors and hedge funds.
A number of analysts have commented on the company. Zacks Investment Research cut VWR from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. BidaskClub cut VWR from a “sell” rating to a “strong sell” rating in a report on Saturday, September 2nd. Finally, ValuEngine cut VWR from a “buy” rating to a “hold” rating in a report on Wednesday, October 11th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $31.67.
VWR (NASDAQ:VWR) last posted its quarterly earnings results on Tuesday, November 7th. The medical research company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.08. The business had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.16 billion. VWR had a return on equity of 11.79% and a net margin of 4.11%. The business’s revenue was up 5.2% compared to the same quarter last year. During the same period in the prior year, the business earned $0.44 earnings per share. equities research analysts anticipate that VWR Corp will post 1.85 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “Russell Investments Group Ltd. Decreases Holdings in VWR Corp (NASDAQ:VWR)” was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://stocknewstimes.com/2017/12/06/vwr-corporation-vwr-shares-sold-by-russell-investments-group-ltd.html.
VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.
Receive News & Ratings for VWR Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corp and related companies with MarketBeat.com's FREE daily email newsletter.